Syntegon Technology GmbH
Syntegon
Born as Bosch Packaging Technology and reborn as Syntegon in 2020, this German engineering house has become the innovation engine of pharmaceutical packaging. Headquartered in Waiblingen, Syntegon designs aseptic filling, freeze-drying and flexible food packaging lines that set the industry's cleanroom standard. FY2025 was a record year: revenue rose 10% to €1.75 billion, new orders reached €1.86 billion, and adjusted EBITDA jumped 27% to €282 million (16.1% margin) as the company tilted toward high-profit biologics lyophilization and sterile filling lines. With 6,900+ employees, about 1,400 of them pure R&D engineers, and 2,100+ patents, Syntegon combines Bosch-grade process discipline with startup-like agility.
Strengths:
• Pharma packaging benchmark: its SynTiso system — the world's first glove-free high-speed aseptic filling line for liquid drugs — eliminates operator-induced contamination risk.
• Record order momentum: €1.86 billion of new orders in 2025 secure high revenue visibility into 2026.
• Deep intellectual property: more than 2,100 patents and ~1,400 R&D staff give it a technology moat in freeze-drying and aseptic processing.
• Bosch DNA of process excellence: lean manufacturing and global service discipline inherited from decades inside the Bosch group.
• Telstar integration: the acquired lyophilization and cleanroom specialist completes the sterile line portfolio.
Weaknesses:
• Ownership uncertainty: CVC Capital is exploring a sale; acquisition by GEA or Coesia could unsettle long-term customers and R&D independence.
• Narrow end-market focus: heavy dependence on pharma and food packaging leaves limited diversification into other machinery segments.
• European cost base: high German engineering costs are only partly offset by the new engineering hub in India.Read MoreShow Less
Strengths:
• Pharma packaging benchmark: its SynTiso system — the world's first glove-free high-speed aseptic filling line for liquid drugs — eliminates operator-induced contamination risk.
• Record order momentum: €1.86 billion of new orders in 2025 secure high revenue visibility into 2026.
• Deep intellectual property: more than 2,100 patents and ~1,400 R&D staff give it a technology moat in freeze-drying and aseptic processing.
• Bosch DNA of process excellence: lean manufacturing and global service discipline inherited from decades inside the Bosch group.
• Telstar integration: the acquired lyophilization and cleanroom specialist completes the sterile line portfolio.
Weaknesses:
• Ownership uncertainty: CVC Capital is exploring a sale; acquisition by GEA or Coesia could unsettle long-term customers and R&D independence.
• Narrow end-market focus: heavy dependence on pharma and food packaging leaves limited diversification into other machinery segments.
• European cost base: high German engineering costs are only partly offset by the new engineering hub in India.
In the press
All coverage →5 latest headlines- Syntegon Launches Annex 1 Roadshow to Bring Solutions To Pharma Customers - Process and Control Todaywww.pandct.com2026-10-14
- Syntegon launches European Annex 1 compliance roadshow - Manufacturing Chemistmanufacturingchemist.com2026-10-12
- Syntegon: in demand during the coronavirus crisis - packaging journalpackaging-journal.de2026-09-05
- Syntegon at CPHI: seamless solutions for liquid and solid pharmaceuticals - Manufacturing Chemistmanufacturingchemist.com2026-09-03
- Tea and Coffee Packaging Machinery Market Outlook 2026-2035 Featuring Strategic Profiles of IMA Group, Syntegon Technology, Coesia Group, GEA Group, Tetra Pak and Regional Powerhouses - Yahoo Financefinance.yahoo.com2026-08-24
• SynTiso glove-free high-speed aseptic filling lines for liquid drugs
• Freeze-drying lyophilization systems incl. Telstar cleanroom technology
• Isolator and containment solutions for biologics
Pharmaceutical Packaging – Core Business
• Blister packing, cartoning and tube filling for pharma
• In-vitro diagnostics and injectable drug packaging lines
Food & Flexible Packaging – Core Business
• Flow-wrapping, bagging and flexible packaging lines for confectionery, bakery and dairy
• Sorting and packaging systems for processed food
Lifecycle Services – Core Business
• Qualification, validation and digital services for regulated environments
• Spare parts, retrofits and predictive maintenance
Quick Facts
Headquarters
Founded
Employees
Revenue
Factories
Presence
Categories
12 categories · scroll for more
Related
Similar listed companies
- Abbott Laboratories· $233 B
- Siemens AG· $223 B
- Danaher Corporation· $206 B
- John Deere· $178 B
- Schneider Electric SE· $152 B
- ABB Ltd· $145 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , Data Sources:
• Syntegon Official Press Release FY2025
• Indian Pharma Post - Syntegon FY25 Results
• Valicare - Bosch to Syntegon History
• Tracxn - Syntegon Profile
